State Street’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-72,696
Closed -$844K 4678
2023
Q1
$844K Buy
72,696
+1,656
+2% +$19.5K ﹤0.01% 3592
2022
Q4
$855K Sell
71,040
-87,791
-55% -$1.14M ﹤0.01% 3597
2022
Q3
$2.07M Buy
158,831
+89,309
+128% +$1.1M ﹤0.01% 3406
2022
Q2
$953K Buy
+69,522
New +$923K ﹤0.01% 3642

Other funds holding BIOX

State Street's BIOX Position: Q2 2023 in Review

State Street sold out of Bioceres Crop Solutions (BIOX) in Q2 2023, closing a stake of 72,696 shares — an estimated $844K sold.

State Street first reported a position in BIOX in Q2 2022 and held it in 4 quarters. The position peaked at $2.07M in Q3 2022. 46 funds tracked by Wall St. Rank hold BIOX as of Q2 2023.

  • State Street reported no remaining Bioceres Crop Solutions position as of Q2 2023 after selling out during the quarter.
  • State Street sold 72,696 Bioceres Crop Solutions shares in Q2 2023, an estimated $844K.
  • State Street first reported a position in Bioceres Crop Solutions in Q2 2022 and held it in 4 quarters.
  • State Street's Bioceres Crop Solutions position peaked at $2.07M in Q3 2022.
  • 46 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.